Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

5 High-Growth Biotechnology Stocks That Analysts Strongly Favor
Seeking Alpha
Saturday, August 25, 2012 - 11:41am
tags:
Pain Therapeutics, Cerus, Zalicus, Merrimack Pharmaceuticals, Cell Therapeutics
Is YM BioSciences the Perfect Penny Stock?
Motley Fool
Saturday, August 25, 2012 - 11:39am
tags:
YM BioSciences
This Just In: More Upgrades and Downgrades
Motley Fool
Saturday, August 25, 2012 - 11:38am
tags:
Discovery Labs, Oncothyreon, Threshold Pharmaceuticals, Puma Biotechnology, Immunogen, Pharmacyclics, Infinity Pharmaceuticals
Maxim Group Highlights 3 Biotech Stocks With Key Milestones Ahead
Seeking Alpha
Saturday, August 25, 2012 - 11:35am
tags:
Ariad, Exelixis, Medgenics
Pluristem to Begin IC Phase II Trial
Yahoo/Zacks
Saturday, August 25, 2012 - 11:34am
tags:
Pluristem, intermittent claudication, placental expanded cells
Healthcare Sector Undervalued, 3 Stocks With Mixed Upside
Motley Fool
Saturday, August 25, 2012 - 11:32am
tags:
Bristol-Myers Squibb, Amgen, Baxter
Branham Law, LLP Announces an Investigation of Chelsea Therapeutics International, Ltd. for Possible Securities Law Violations
Yahoo/BusinessWire
Saturday, August 25, 2012 - 11:31am
tags:
Chelsea Therapeutics, lawsuits
Immunomedics' CEO Discusses F4Q12 Results - Earnings Call Transcript
Seeking Alpha
Saturday, August 25, 2012 - 11:29am
tags:
Immunomedics
Threshold Pharma rises on analyst 'Buy' rating
Yahoo/AP
Saturday, August 25, 2012 - 11:26am
tags:
Threshold Pharmaceuticals
Oncothyreon rises as analyst starts coverage
Yahoo/AP
Saturday, August 25, 2012 - 11:26am
tags:
Oncothyreon
The Most Epic Drug Failure. Ever.
Motley Fool
Saturday, August 25, 2012 - 11:24am
tags:
Bristol-Myers Squibb, BMS-986094, hepatitis C
Merck KGaA to Acquire Biochrom AG
Yahoo/Zacks
Friday, August 24, 2012 - 6:31pm
tags:
Biochrom, Merck KGaA, M&A
Pozen rises on continued FDA drug discussions
Yahoo/AP
Friday, August 24, 2012 - 6:30pm
tags:
Pozen, FDA, PA32540
Forest Labs confirms Icahn nominee will join board
Yahoo/AP
Friday, August 24, 2012 - 6:29pm
tags:
Carl Icahn, Forest Labs
Court sides with Lilly over cancer drug patent
Yahoo/AP
Friday, August 24, 2012 - 5:54pm
tags:
patents, Eli Lilly, Alimta, mesothelioma, lung cancer
Startup biotech hauls in $23M A round for antiviral work
Fierce Biotech
Friday, August 24, 2012 - 11:43am
tags:
Novira Therapeutics
Eli Lilly Alzheimer's drug yields some promise in preliminary results from late-stage study
Yahoo/AP
Friday, August 24, 2012 - 11:41am
tags:
Eli Lilly, Alzheimer's disease, solanezumab
Will Obamacare Drive the Medical Diagnostic and Research Sector Upwards? Expert Analyst Amit Bhalla Details the Near Term Prospects
Yahoo/Wall St Transcript
Friday, August 24, 2012 - 11:37am
tags:
Obama, Obamacare, healthcare reform
Pfizer ends supply deal with Claris Lifesciences
Economic Times, India
Friday, August 24, 2012 - 11:19am
tags:
Claris Lifesciences, Pfizer, India
Pfizer settles Impax patent suit over generic Detrol LA
Reuters
Friday, August 24, 2012 - 11:19am
tags:
Detrol, generics, Pfizer, Impax, patents

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.